KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Arcosa (ACA) Net Income towards Common Stockholders (2017 - 2026)

Arcosa's Net Income towards Common Stockholders history spans 10 years, with the latest figure at $14.5 million for Q1 2026.

  • On a quarterly basis, Net Income towards Common Stockholders rose 20.83% to $14.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $225.3 million, a 145.69% increase, with the full-year FY2025 number at $234.4 million, up 97.14% from a year prior.
  • Net Income towards Common Stockholders hit $14.5 million in Q1 2026 for Arcosa, down from $78.1 million in the prior quarter.
  • Over the last five years, Net Income towards Common Stockholders for ACA hit a ceiling of $199.4 million in Q4 2022 and a floor of $12.0 million in Q1 2025.
  • Historically, Net Income towards Common Stockholders has averaged $49.3 million across 5 years, with a median of $39.2 million in 2024.
  • Biggest five-year swings in Net Income towards Common Stockholders: soared 845.02% in 2022 and later plummeted 70.46% in 2023.
  • Tracing ACA's Net Income towards Common Stockholders over 5 years: stood at $199.4 million in 2022, then plummeted by 70.46% to $58.9 million in 2023, then plummeted by 70.29% to $17.5 million in 2024, then surged by 346.29% to $78.1 million in 2025, then tumbled by 81.43% to $14.5 million in 2026.
  • Business Quant data shows Net Income towards Common Stockholders for ACA at $14.5 million in Q1 2026, $78.1 million in Q4 2025, and $73.0 million in Q3 2025.